SlideShare a Scribd company logo
LABORATORY REPORT
: P135671
: 27/11/2021 4:18 PM
: 27/11/2021 4:36 PM
: 28/11/2021 5 :40 PM
:
Patient ID
Registered On
Collected On
Reported On
External Id
: Mohammed Anas C S
: V134277
: 26 Y/ M
Name
Visit No
Age/Gender
Ref By
Aadhar Card
DOB
: Kalarikkal X ray, Ramanattukara
: 8028 4823 8072
: 27/02/1995
MOLECULAR BIOLOGY REPORT
Test Name : COVID 19 SARS CoV 2 Detection by Qualitative Real Time PCR
ICMR Registration Number: CARREFLABVKK
SARS-CoV-2 Detection by Real Time Polymerase Chain Reaction
TEST RESULT
SARS-COV2 NEGATIVE
Specimen Type :
Method :
Nasopharyngeal/Oropharyngeal swab
RTPCR
This Real Time Polymerase Chain Reaction test intended to use for the qualitative detection of a novel corona virus which was identified in 2019 at
Wuhan City, Hubei province, China in upper respiratory tract specimens and lower respiratory tract specimens of infected people.
Pathogen information :
Corona viruses (CoV) are a large family of viruses that cause illness ranging from common cold to more severe diseases such as Middle East
Respiratory Syndrome (MERS -CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). SARS-CoV-2 (COVID-19) is a new strain that has not
been previously identified in humans.
Interpretation :
A "POSITIVE" result indicates that Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) RNA is present in the given sample and
suggests the diagnosis of coronavirus disease 2019 (COVID-19). Test result should always be considered in the context of patient's clinical history,
physical examination, and epidemiologic exposures.
A "NEGATIVE" result indicates that SARS-CoV-2 is not present in the patient's given specimen. Result should be correlated with patient’s history
and clinical presentation. However it does not rule out the infection completely and should not be used as the sole basis for making decisions related
to treatment and other patient management decisions. A false negative may resulted due to inadequate number of organisms are present in the
specimen due to improper collection, transport or handling
Note: The results relate only to the specimens tested and should be correlated with clinical findings
Interpretation guidance:
1. Testing of referred clinical specimens was considered on the basis of request/referral received
from/ through state surveillance officer(SSO) of concerned State Integrated Disease Surveillance
Programme / any other health care facility affirming requirements of the case definition/s
2.A single negative test result, particularly if this is from an upper respiratory tract specimen, does not exclude infection
3.A positive test result is only tentative, and will be reconfirmed by retesting.
4.Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease. The repeat specimens may be
considered after a gap of 2-4 days after the collection of the first specimen for additional testing if required
5.A positive alternate pathogen does not necessarily rule out either, as little is yet known about the role of coinfections
*** End of Report ***
Page 1 of 1
Dr. Ronald A Roche
MD Microbiology
Consultant Microbiologist
Dr. Reshmi Gopalakrishnan
MD Microbiology
Consultant Microbiologist

More Related Content

What's hot

Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr 210906183229
Rtpcr 210906183229Rtpcr 210906183229
Rtpcr 210906183229
Care Reference Laboratory
 
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838
Care Reference Laboratory
 
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838
Care Reference Laboratory
 
Rtpcr
RtpcrRtpcr

What's hot (19)

Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr 210906183229
Rtpcr 210906183229Rtpcr 210906183229
Rtpcr 210906183229
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838Rtpcr 210906183229-210909100838
Rtpcr 210906183229-210909100838
 
Rtpcr
RtpcrRtpcr
Rtpcr
 

Similar to Rtpcr

Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745
Care Reference Laboratory
 
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr 210930041407
Rtpcr 210930041407Rtpcr 210930041407
Rtpcr 210930041407
Care Reference Laboratory
 
Rtpcr
RtpcrRtpcr
Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745
Care Reference Laboratory
 
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr

Similar to Rtpcr (20)

Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr 210930041407
Rtpcr 210930041407Rtpcr 210930041407
Rtpcr 210930041407
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745Rtpcr 21093004140-211003083745
Rtpcr 21093004140-211003083745
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 

More from Care Reference Laboratory

Rtpcr
RtpcrRtpcr
Certificate
Certificate Certificate
Certificate
Certificate Certificate
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Rtpcr
RtpcrRtpcr
Nidhi subash rtpcr
Nidhi subash rtpcrNidhi subash rtpcr
Nidhi subash rtpcr
Care Reference Laboratory
 

More from Care Reference Laboratory (20)

Rtpcr
RtpcrRtpcr
Rtpcr
 
Certificate
Certificate Certificate
Certificate
 
Certificate
Certificate Certificate
Certificate
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Rtpcr
RtpcrRtpcr
Rtpcr
 
Nidhi subash rtpcr
Nidhi subash rtpcrNidhi subash rtpcr
Nidhi subash rtpcr
 

Recently uploaded

Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
AyushGadhvi1
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 

Recently uploaded (20)

Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 

Rtpcr

  • 1. LABORATORY REPORT : P135671 : 27/11/2021 4:18 PM : 27/11/2021 4:36 PM : 28/11/2021 5 :40 PM : Patient ID Registered On Collected On Reported On External Id : Mohammed Anas C S : V134277 : 26 Y/ M Name Visit No Age/Gender Ref By Aadhar Card DOB : Kalarikkal X ray, Ramanattukara : 8028 4823 8072 : 27/02/1995 MOLECULAR BIOLOGY REPORT Test Name : COVID 19 SARS CoV 2 Detection by Qualitative Real Time PCR ICMR Registration Number: CARREFLABVKK SARS-CoV-2 Detection by Real Time Polymerase Chain Reaction TEST RESULT SARS-COV2 NEGATIVE Specimen Type : Method : Nasopharyngeal/Oropharyngeal swab RTPCR This Real Time Polymerase Chain Reaction test intended to use for the qualitative detection of a novel corona virus which was identified in 2019 at Wuhan City, Hubei province, China in upper respiratory tract specimens and lower respiratory tract specimens of infected people. Pathogen information : Corona viruses (CoV) are a large family of viruses that cause illness ranging from common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS -CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). SARS-CoV-2 (COVID-19) is a new strain that has not been previously identified in humans. Interpretation : A "POSITIVE" result indicates that Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) RNA is present in the given sample and suggests the diagnosis of coronavirus disease 2019 (COVID-19). Test result should always be considered in the context of patient's clinical history, physical examination, and epidemiologic exposures. A "NEGATIVE" result indicates that SARS-CoV-2 is not present in the patient's given specimen. Result should be correlated with patient’s history and clinical presentation. However it does not rule out the infection completely and should not be used as the sole basis for making decisions related to treatment and other patient management decisions. A false negative may resulted due to inadequate number of organisms are present in the specimen due to improper collection, transport or handling Note: The results relate only to the specimens tested and should be correlated with clinical findings Interpretation guidance: 1. Testing of referred clinical specimens was considered on the basis of request/referral received from/ through state surveillance officer(SSO) of concerned State Integrated Disease Surveillance Programme / any other health care facility affirming requirements of the case definition/s 2.A single negative test result, particularly if this is from an upper respiratory tract specimen, does not exclude infection 3.A positive test result is only tentative, and will be reconfirmed by retesting. 4.Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease. The repeat specimens may be considered after a gap of 2-4 days after the collection of the first specimen for additional testing if required 5.A positive alternate pathogen does not necessarily rule out either, as little is yet known about the role of coinfections *** End of Report *** Page 1 of 1 Dr. Ronald A Roche MD Microbiology Consultant Microbiologist Dr. Reshmi Gopalakrishnan MD Microbiology Consultant Microbiologist